. Marriott President and CEO Arne Sorenson Will Reduce Schedule for Cancer Treatment | Northstar Meetings Group

Marriott President and CEO Arne Sorenson Will Reduce Schedule for Cancer Treatment

The hotel company has named interim managers to share the responsibility for day-to-day operations temporarily.

Arne Sorenson Marriott President CEO Cancer Treatments

Marriott International president and CEO Arne Sorenson, who has been battling pancreatic cancer since May 2019, will temporarily reduce his work schedule to focus on more intensive medical treatment. Sorenson will remain president and CEO and will continue to be involved in directing the company, as well as retain his seat on the board of directors.

To oversee the day-to-day operations of Marriott's business units, Sorenson and the board have tapped two veteran company executives. Stephanie Linnartz, group president of consumer operations, technology and emerging businesses, will oversee Marriott's international lodging division, as well as legal, human resources, and communications and public affairs. Tony Capuano, group president of global development, design and operations services, will oversee the U.S. and Canada lodging division and finance.

The new roles are in addition to the leaders' respective current responsibilities. Neither is a stranger to the Marriott team: Linnartz has been with the company since 1997 and Capuano joined Marriott in 1995.

"Since my diagnosis, I’ve been working with a great medical team at Johns Hopkins to treat this cancer,” said Sorenson. "While I have worked throughout my treatment to date, and plan to remain as engaged in the business as my health allows, the right thing to do for me, my family and the company is to focus on my health. I know Stephanie and Tony will work with Marriott’s strong executive team to continue to move the company forward."

Sorenson underscored that the changes are meant to be temporary. "I, along with my family and my medical team, remain optimistic about my prognosis, and I plan to return full-time after the conclusion of my treatments."